Medcamp S.A. (WSE:MDP) agreed additional 34% stake in genXone S.A from Torox Eko FIZAN fund managed by AgioFunds Towarzystwo Funduszy Inwestycyjnych S.A. on March 13, 2020. As per the agreement, Medcamp S.A. will acquire shares at PLN 6.9 per share. Upon completion, Medcamp S.A will hold 50% stake in genXone S.A.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.78 PLN | -6.47% | -5.86% | +7.43% |
13/05 | GenXone S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
12/02 | GenXone S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+7.43% | 5.17M | |
+16.20% | 78.51B | |
+13.92% | 9B | |
+42.06% | 4.96B | |
-14.54% | 4.84B | |
+9.01% | 3.72B | |
+21.94% | 2.48B | |
-27.22% | 2.19B | |
+15.83% | 2.12B | |
-39.50% | 1.94B |
- Stock Market
- Equities
- GX1 Stock
- News genXone S.A.
- Medcamp S.A. agreed additional 34% stake in genXone S.A from Torox Eko FIZAN fund managed by AgioFunds Towarzystwo Funduszy Inwestycyjnych S.A.